Login
$EMMA
$0.06 -$0.00 (1.73%) Close

$EMMA 3 SEC Filings

Filed On Filing
21 Apr 2026 Form 3: Du Henry Huy, Director

No securities owned

09 Oct 2024 Form 3: Kuwahara Jon, Director

No securities owned

06 Oct 2022 Form 3: Zwicker Ian Harvey, Director
06 Oct 2022 Form 3: Lim Seah H., Director
24 Jan 2022 Form 3: Teranishi Lori, Director

Holds 18,161 shares of Common stock, $0.001 par value

28 Dec 2021 Form 3: Stark Charles William, SVP, Clinical Development

Holds 3,480 shares of Common stock, $0.001 par value

20 Dec 2021 Form 3: Sekulich George, CIO & SVP

Holds 385 shares of Common stock, $0.001 par value

30 Nov 2021 Form 3: Lui Alfred Fu Kong, Director

Holds 32,358 shares of Common stock, $0.001 par value

24 Apr 2020 Form 3: Wood Jane Pine, Director

No securities owned

11 Sep 2019 Form 3: Osato Masaharu, Director

Holds 2,215 shares of Common stock, $0.001 par value

30 Jul 2019 Form 3: Zen Wei Peu, Director

Holds 1,007,833 shares of Common stock, $0.001 par value

30 Jul 2019 Form 3: Dickey Robert Iv, Director

No securities owned

30 Jul 2019 Form 3: Tran Lan T., Chief Administrative Officer

Holds 26,562 shares of Common stock, $0.001 par value

29 Jul 2019 Form 3: Niihara Yutaka, Director

Holds 10,162,126 shares of Common stock, $0.001 par value

26 Jul 2019 Form 3: Nagasaki Yasushi, Sr. VP Finance

Holds 67,102 shares of Common stock, $0.001 par value

26 Jul 2019 Form 3: Zwicker Ian Harvey, Director
26 Jul 2019 Form 3: Lee Willis C, Director

Holds 185,784 shares of Common stock, $0.001 par value

14 Dec 2018 Form 3: Herguth Patrick, Director
21 Sep 2017 Form 3: Unanue Peter, Director

Holds 38,100 shares of Common Stock

03 Apr 2017 Form 3: D'Ambrosio Donald Eric, Chief Financial Officer

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support